Magellan Raises $50 Million

Magellan Biosciences, a Chelmsford, Mass.-based provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing, has raised $50 million in new private equity and debt funding. Abingworth Management led the deal, and was joined by Hambrecht & Quist Capital Management, KBL Healthcare Ventures and return backers Ampersand Ventures, New England Partners Capital, Nexus Medical Partners and Boston Community Venture Fund. www.magellanbio.com